| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0304-3940(77)90183-5 |
| P8608 | Fatcat ID | release_tdlb2dfry5b57ogbtjiihbfy7u |
| P698 | PubMed publication ID | 19556189 |
| P5875 | ResearchGate publication ID | 26320474 |
| P2093 | author name string | Magelund G | |
| Scheel-Krüger J | |||
| Arnt J | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substantia nigra | Q753278 |
| P304 | page(s) | 351-356 | |
| P577 | publication date | 1977-05-01 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Behavioural stimulation induced by muscimol and other GABA agonists injected into the substantia nigra. | |
| P478 | volume | 4 |
| Q67288349 | 3Hquinuclidinyl benzylate and 3HGABA receptor binding in rat substantia nigra after 6-hydroxy-dopamine lesions |
| Q39223366 | Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity |
| Q41480600 | Allylglycine: Intranigral effects and reappraisal of actions on the GABA system |
| Q41035354 | Amphetamine-induced circling behavior in rats: Effects of unilateral microinjections of GABA and GABA-related drugs into substantia nigra |
| Q72422527 | An in vivo method for testing putative GABA-like compounds |
| Q49043576 | Apomorphine-induced ipsilateral turning in rats with unilateral lesions of the parafascicular nucleus |
| Q41752157 | Baclofen and muscimol: Behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding |
| Q70459493 | Basal ganglia outflow pathways and circling behaviour in the rat |
| Q67020109 | Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia Nigra |
| Q71012259 | Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat |
| Q49159166 | Behavioural effects of GABA-agonists and antagonists infused in the mesencephalic reticular formation - deep layers of superior colliculus |
| Q39217999 | Behavioural evidence for GABAergic activity of the benzodiazepine flurazepam |
| Q48949742 | Bicuculline-induced circling from the rat superior colliculus is blocked by GABA microinjection into the deep cerebellar nuclei |
| Q28317257 | Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines |
| Q48404370 | Catecholamine release within the striatum of the freely moving rat. |
| Q40127257 | Cellular compartments of GABA in brain and their relationship to anticonvulsant activity |
| Q43338892 | Central GABA activation and behaviors evoked by tail-pinch stress in the rat. |
| Q45270665 | Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity |
| Q59060124 | Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra |
| Q71509695 | Circling behavior induced by intranigral injections of GABA and muscimol in rats |
| Q39185745 | Circling behaviour in the rat following unilateral injections of p-chlorophenylalanine and ethanol-amine-O-sulphate into the substantia nigra |
| Q41702249 | Contralateral turning after unilateral electrolytic lesion of substantia nigra in thalamic rats |
| Q48152701 | Contralateral turning evoked by the intranigral microinjection of muscimol and other GABA agonists |
| Q39270649 | Decreased antistereotypic effect of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound |
| Q40191450 | Denervation supersensitivity in the striatonigral GABA pathway |
| Q70340353 | Determination of the gamma-aminobutyric acid agonist 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridine-3-ol in urine by high-performance liquid chromatography |
| Q48857354 | Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro. |
| Q71564923 | Differential effects of IV and IP muscimol on central dopamine metabolism |
| Q48165407 | Differential effects of chronic treatment with chlorpromazine versus cocaine on behavioral responsiveness to nigral GABA receptor stimulation |
| Q48172402 | Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei |
| Q40090581 | Dopamine and antianxiety activity |
| Q70883065 | Dopamine independent rotational response to unilateral intranigral injection of serotonin |
| Q40725807 | Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway |
| Q67019731 | Drug-induced stereotypes and asymmetric behaviour after substantia nigra pars posterior (SNPP) lesions in cats |
| Q40085825 | Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications |
| Q48645581 | Effect of intranigral injections of dynorphin, dynorphin fragments and α-neoendorphin on rotational behaviour in the rat |
| Q70503755 | Effect of intrastriatal administration of cholinergic and GABAergic agonists on apomorphine-induced circling |
| Q72884764 | Effect of sodium valproate on motor function regulated by the activation of GABA receptors |
| Q48823795 | Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat |
| Q49158173 | Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes |
| Q70179841 | Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat |
| Q48641478 | Effects of intranigral injections of dopamine agonists and antagonists, glycine, muscimol and N- methyl-D,L-aspartate on locomotor activity |
| Q72899705 | Effects of some GABA-mimetic drugs on the antinociceptive activity of morphine and beta-endorphin in rats |
| Q41529036 | Effects of the GABA Receptor Agonist Muscimol on the Turnover of Brain Dopamine and on the Motor Activity of Rats |
| Q34520311 | Effects of transient focal inactivation of the basal ganglia in parkinsonian primates. |
| Q39709689 | Electrophysiological and behavioural correlations during the manipulations of GABA functions in the Substantia Nigra by n-dipropylacetate and Picrotoxin |
| Q70586687 | Enhanced GABA function in the angular complex (lateral periaqueductal grey matter and adjacent reticular formation) alters the postural component of striatal- or nigral-derived circling |
| Q33914211 | Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats |
| Q52299799 | Enhanced suppression of a conditioned avoidance response by haloperidol but not phenoxybenzamine in rats with bilateral parafascicular lesions. |
| Q66974702 | Evidence that GABA in the nucleus dorsalis raphé induces stimulation of locomotor activity and eating behavior |
| Q72729810 | Evidence that nigral substance P controls the activity of the nigrotectal GABAergic pathway |
| Q37362143 | Expression of c-fos mRNA in the basal ganglia associated with contingent tolerance to amphetamine-induced hypophagia |
| Q39838625 | GABA Receptor Agonists: Relationship Between Structure and Biological Activity In Vivo and In Vitro |
| Q40265735 | GABA agonists and potential antagonists related to muscimol |
| Q54130707 | GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias. |
| Q70981177 | GABA in the entopeduncular nucleus and the subthalamic nucleus participates in mediating dopaminergic striatal output functions |
| Q43422317 | GABA in the ventral tegmental area: Differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists |
| Q39222804 | GABA involvement in neuroleptic-induced catalepsy |
| Q71338855 | GABA mediated circling from substantia nigra |
| Q51869622 | GABA-ergic mechanisms in central respiratory control in the anesthetized rat |
| Q73134792 | GABAA receptor antagonists reduce acute opiate withdrawal in isolated tissue |
| Q46170895 | GABAB receptors are involved in the control of acute opiate withdrawal in isolated tissue |
| Q39259456 | GABAergic and glycinergic mechanisms within the substantia nigra: Pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters |
| Q72844350 | GABAergic denervation of rat substantia nigra: functional and pharmacological properties |
| Q72951808 | Glycine Antagonists Structurally Related to Muscimol, THIP, or Isoguvacine |
| Q72919079 | Gnawing and changes in reactivity produced by microinjections of picrotoxin into the superior colliculus of rats |
| Q26862775 | Hemispheric differences in the mesostriatal dopaminergic system |
| Q51599063 | Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysis |
| Q39209500 | Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats |
| Q55346203 | Inhibition of the substantia nigra pars reticulata produces divergent effects on sensorimotor gating in rats and monkeys. |
| Q48679927 | Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase |
| Q45038523 | Intranigral infusion of enkephalins elicits dyskinetic biting in rats |
| Q72898327 | Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection |
| Q69028589 | Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA |
| Q49153650 | Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat |
| Q46670529 | Motor stimulant effects of ethanol injected into the substantia nigra pars reticulata: importance of catalase-mediated metabolism and the role of acetaldehyde |
| Q48248345 | Muscimol a GABA-agonist injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility |
| Q39257992 | Muscimol and related GABA receptor agonists: the potency of GABAergic drugs in vivo determined after intranigral injection |
| Q43946168 | Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: A complex GABA-dopamine interaction |
| Q45303775 | Neurotransmitters in Huntington's Chorea—a Clinician's View |
| Q49091501 | Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam |
| Q42523069 | Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons |
| Q66976703 | Nipecotic acid and guvacine antagonism on morphine analgesia in rats |
| Q39595744 | Ontogeny of GABA-ergic and dopaminergic mediation of gnawing behavior in the mouse |
| Q49090252 | Oral behaviour induced by intranigral muscimol is unaffected by haloperidol but abolished by large lesions of superior colliculus |
| Q40132011 | Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist |
| Q40123436 | Physiological and behavioral studies with muscimol |
| Q74241869 | Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus |
| Q39270287 | Potentiation of muscimol-induced hyperactivity by benzodiazepines |
| Q71093478 | Preliminary Studies on the Absorption, Distribution, Metabolism, and Excretion of THIP in Animal and Man using 14C‐labelled Compound |
| Q41702015 | Rapid behavioural and biochemical effects of tetanus toxin microinjected into the substantia nigra: A dual role for GABA? |
| Q39216936 | Regional changes in the concentrations of cerebral monoamines and their metabolites after ethanolamine-O-sulphate induced elevation of brain γ-aminobutyric acid concentrations |
| Q72466764 | Relationship between the presence of dopaminergic neurons and GABA receptors in substantia nigra: Effects of lesions |
| Q39580547 | Relevance of GABA in the Nigrostriatal System |
| Q48580531 | Role of the cat substantia nigra pars reticulata in eye and head movements. II. Effects of local pharmacological injections |
| Q48301369 | Selective neurokinin NK1 and NK2 receptor agonists infused in the substantia nigra of the rat increase vacuous chewing |
| Q45403732 | Striatal dopamine release and contraversive rotation elicited by intranigrally applied muscimol |
| Q48847985 | Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: Striatal dopamine and GABA-mediated responses of pars reticulata neurons |
| Q48095944 | Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons |
| Q71079860 | Taurine and Thermoregulation: Behavioral and Cellular Studies |
| Q67282190 | The acute effect of the GABA-agonist, THIP, on proprioceptive and flexor reflexes in spastic patients |
| Q54532984 | The effects of muscimol and picrotoxin injections into the cat Substantia nigra |
| Q48508129 | The importance of the striato-nigro-collicular pathway in the expression of haloperidol-induced tonic electromyographic activity |
| Q72466803 | The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra |
| Q40082826 | The physiology and pharmacology of mammalian basal ganglia |
| Q44574661 | The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence |
| Q43562154 | The role of GABA in the substantia nigra |
| Q66986020 | The role of monoamines for the central effects of Baclofen on behavior of rats |
| Q48186755 | The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral gabaergic pathway |
| Q38075185 | The striatum and substantia nigra: A commentary on their relationships |
| Q44736247 | The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats |
| Q71687261 | The subthalamo-nigral pathway regulates movement and concomitant acetylcholinesterase release from the substantia nigra |
| Q42515211 | Topography of dyskinesias and torticollis evoked by inhibition of substantia nigra pars reticulata |
| Q71880177 | Turning behavior in rats with unilateral lesions of the subthalamic nucleus: synergism between D1 and D2 receptors |
| Q48906972 | Turning behavior induced by injections of glutamate receptor antagonists into the substantia nigra of the rat. |
| Q40097845 | Turning behaviour in animals |
| Q41027159 | Turning behaviour induced by injection of muscimol or picrotoxin into the substantia nigra demonstrates dual GABA components |
| Q67408888 | Ultrapotent chemogenetics for research and potential clinical applications. |
| Q48700618 | γ-Aminobutyric Acid and Basal Ganglia Outflow Pathways |
Search more.